| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |